PUBLISHER: The Business Research Company | PRODUCT CODE: 1951654
PUBLISHER: The Business Research Company | PRODUCT CODE: 1951654
Contraceptives refer to methods or practices that involve the use of various medicines, sexual behaviors, chemicals, medications, or surgical procedures to deliberately prevent conception. A contraceptive is any method, measure, or action intended to prevent a woman from becoming pregnant.
The primary product types of contraceptives include oral contraceptive pills, topical contraceptives, injectables, diaphragms, vaginal rings, condoms, contraceptive sponges, subdermal implants, and intrauterine devices. Oral contraceptive pills, also known as birth control pills, are tablets taken to prevent pregnancy and contain hormones that inhibit the release of eggs from the ovaries. Contraceptives are used by a broad range of age groups, including individuals aged 15-24 years, 25-34 years, 35-44 years, and over 44 years. These products are distributed through clinics, hospitals, independent pharmacies, and other outlets.
Tariffs have impacted the contraceptives market by increasing the cost of imported active pharmaceutical ingredients, medical-grade polymers, and device components used in pills, condoms, implants, and IUDs. This has affected pricing and supply stability across oral contraceptives, intra-uterine devices, and subdermal implants, with Asia-Pacific and Latin America being most impacted due to reliance on cross-border manufacturing. However, tariffs have also encouraged regional manufacturing, local sourcing, and strategic partnerships, supporting supply chain resilience and long-term domestic production growth.
The contraceptives market research report is one of a series of new reports from The Business Research Company that provides contraceptives market statistics, including contraceptives industry global market size, regional shares, competitors with a contraceptives market share, detailed contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptives industry. This contraceptives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The contraceptives market size has grown strongly in recent years. It will grow from $29.74 billion in 2025 to $32.02 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to government-led family planning initiatives, increased availability of oral contraceptive pills, rising urban female workforce participation, public health campaigns on population control, expansion of hospital and clinic-based contraceptive services.
The contraceptives market size is expected to see strong growth in the next few years. It will grow to $43.09 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to growth in non-hormonal and male contraceptive innovation, rising penetration of online pharmacies, increasing reproductive health awareness among adolescents, technological advancements in implantable devices, supportive regulatory approvals for novel contraceptives. Major trends in the forecast period include rising adoption of long-acting reversible contraceptives, increasing preference for non-hormonal contraceptive options, growing demand for female-controlled contraceptive methods, expansion of over-the-counter and self-administered products, increasing focus on adolescent and young adult contraceptive awareness.
The global increase in population levels is anticipated to drive the growth of the contraceptive market in the coming years. Population refers to the total number of individuals or people living within a specific geographic area, country, or across the world. Contraceptives play an important role in population control by enabling individuals and couples to plan families, manage household size, and space childbirth. For example, in December 2024, the United States Census Bureau, a US-based federal agency, reported that the US population reached 340.1 million as of July 1, 2024, representing a 0.98% increase from 336.8 million in 2023-the highest annual growth rate recorded. Consequently, the global rise in population rates is fueling the growth of the contraceptive market.
Leading companies operating in the contraceptives market are concentrating on the development of innovative products, such as Opill, a progestin-only daily oral contraceptive, to better address the needs of existing consumers. Opill progestin-only daily oral contraceptives, commonly referred to as the mini-pill, are a type of birth control pill that contains only progestin, a synthetic form of the hormone progesterone. For example, in July 2023, Perrigo Company plc, an Ireland-based manufacturer of over-the-counter pharmaceuticals, announced that the US Food and Drug Administration (FDA) had approved Opill progestin-only daily oral contraceptives. Opill became the first birth control pill available without a prescription in the United States, significantly improving access to contraceptives for women and demonstrating Perrigo's ongoing commitment to delivering impactful solutions that enhance quality of life.
In March 2024, Insud Pharma, a Spain-based pharmaceutical manufacturing company, acquired oral and injectable contraceptive products from Viatris for an undisclosed amount. Through this acquisition, Insud Pharma seeks to strengthen its women's health portfolio by incorporating Viatris' oral and injectable contraceptives, thereby expanding its market presence and offering a wider range of reproductive healthcare solutions to address the growing demand for contraceptive options. Viatris is a US-based pharmaceutical manufacturing company.
Major companies operating in the contraceptives market are Merck & Co. Inc., Bayer AG, Church & Dwight Co. Inc., Cipla Inc., Reckitt Benckiser Group plc, Agile Therapeutics Inc., Allergan Ltd., Aurobindo Pharma Limited, Famy Care Ltd., Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson, Laboratoire HRA Pharma SAS, Lupin Limited, Mankind Pharma Ltd., Mayer Laboratories Inc., Mithra Pharmaceuticals SA, Mylan NV, Okamoto Industries Inc., Pfizer Inc., Pregna International Ltd., Syncom Pharmaceuticals, Teva Pharmaceutical Industries Ltd., The Population Council, Veru Inc., Zydus Cadila, Shanghai Dahua Pharmaceutical Co. Ltd., Sichuan Kangdi Pharmaceutical Co. Ltd., Beijing Zhengyuan Pharmaceutical Co. Ltd., Zhejiang Huahai Pharmaceutical Co. Ltd., Chongqing Pharmaceutical Group Co. Ltd.
North America was the largest region in the contraceptives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The contraceptive market consists of sales of combined pills, Contraceptive patch, and female condoms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Contraceptives Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The contraceptives market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.